Investors Give the Green Light: Shareholders Vote in Favor of Sanuwave SPAC Merger

SEP Acquisition Corp. (NASDAQ:SEPA) shareholders have given the nod to the proposed merger with Sanuwave Health (OTCQB:SNWV), a company specializing in wound care products.

The merger will see Sanuwave’s shares elevated to the Nasdaq, with an expected retention of the same symbol, SNWV.

SEP disclosed the vote in an SEC filing but did not specify the closing date.

SEP and Sanuwave announced the merger plan in August. The deal values the combined entity at an estimated enterprise value of $127.5M.

Sanuwave boasts two FDA-approved medical devices for wound treatment. Its flagship product, UltraMist, enjoys nationwide schedule 1 reimbursement by the Centers for Medicare and Medicaid Services.